- Home
- ILAG vs CARA Comparison
ILAG vs CARA Comparison
Compare ILAG & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- CARA
- Stock Information
- Founded
- ILAG 1981
- CARA 2004
- Country
- ILAG Hong Kong
- CARA United States
- Employees
- ILAG N/A
- CARA N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- CARA Biotechnology: Pharmaceutical Preparations
- Sector
- ILAG Consumer Discretionary
- CARA Health Care
- Exchange
- ILAG Nasdaq
- CARA Nasdaq
- Market Cap
- ILAG 18.4M
- CARA 15.1M
- IPO Year
- ILAG 2022
- CARA 2014
- Fundamental
- Price
- ILAG $1.01
- CARA $0.31
- Analyst Decision
- ILAG
- CARA Hold
- Analyst Count
- ILAG 0
- CARA 3
- Target Price
- ILAG N/A
- CARA $1.00
- AVG Volume (30 Days)
- ILAG 15.2K
- CARA 833.4K
- Earning Date
- ILAG 11-29-2024
- CARA 11-26-2024
- Dividend Yield
- ILAG N/A
- CARA N/A
- EPS Growth
- ILAG N/A
- CARA N/A
- EPS
- ILAG N/A
- CARA N/A
- Revenue
- ILAG $6,443,357.00
- CARA $8,686,000.00
- Revenue This Year
- ILAG N/A
- CARA N/A
- Revenue Next Year
- ILAG N/A
- CARA N/A
- P/E Ratio
- ILAG N/A
- CARA N/A
- Revenue Growth
- ILAG N/A
- CARA N/A
- 52 Week Low
- ILAG $0.33
- CARA $0.24
- 52 Week High
- ILAG $1.35
- CARA $1.31
- Technical
- Relative Strength Index (RSI)
- ILAG 46.95
- CARA 53.43
- Support Level
- ILAG $0.96
- CARA $0.32
- Resistance Level
- ILAG $1.07
- CARA $0.37
- Average True Range (ATR)
- ILAG 0.05
- CARA 0.03
- MACD
- ILAG -0.00
- CARA 0.00
- Stochastic Oscillator
- ILAG 36.50
- CARA 46.88
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.